Most Americans likely will not benefit immediately from efforts to lower prescription prices. Administration officials expect effects to spread as markets are reshaped.

The Trump administration introduced Tuesday a new drug pricing model that seeks to allow Medicare Part D plans and state Medicaid agencies to cover GLP-1s, potentially expanding coverage for the medications treating obesity and diabetes.

“It’s $1 trillion in cuts over a decade and $50 billion to help try to shore it up,” Rob Davidson, an emergency physician in rural West Michigan told TPM in July. “That’s 5% of the problem in a 5 year span. That math doesn’t work out.”

Some of 2026 changes have prompted significant concern, and experts have warned millions will lose access to health care coverage.

The healthcare industry will see significant changes in 2026 as several of President Donald Trump’s policies take effect in the new year. The president and Health and Human Services Secretary Robert F.

President Donald Trump sparked health concerns as he addressed the rocketing prices of medicine and drugs in the US. Announcing his plan to try and lower the cost of Medicare in the US during a speech in Palm Beach, Florida, he claimed that while UK drug prices would double, the US would see drug costs "decrease by 3000%", thanks to his plan.

As Minnesota Democrats stood accused of allowing massive fraud, critics of the president said he pardoned a fraudster who stole far more.

President Donald Trump on Friday afternoon announced that nine major pharmaceutical companies have agreed to join his "most favored nation" pricing policy, bringing down the price of prescription drugs for Medicare and Medicaid recipients. The deal ensures ...